Some rooms in four Paris hotels of the Accor group, located near the Bichat (18th century), La Pitié-Salpêtrière (13th century) and Avicenne (Bobigny, Seine-Saint-Denis) hospitals, are again occupied. Not by customers. But by people tested positive for Covid-19 and asymptomatic or not requiring hospitalization. "A measure implemented in recent days," said Emmanuel Grégoire, first deputy to the mayor of Paris.
These particular “hosts”, placed on a voluntary basis, will stay in their room for 14 days before returning to their respective homes. Called "Covisan", the operation has just been implemented by the AP-HP in partnership with the City of Paris, the Seine-Saint-Denis departmental council and the Accor group.
Break the chain of transmission
It must make it possible to fight against “intra-family” contagions during confinement and to limit the risks of a “second wave” of contaminations. “It's a major program. It aims to accelerate the break in the chains of transmission and to secure the prospect of deconfinement ”, welcomed Martin Hirsch, boss of the AP-HP, in an email sent this Saturday to his teams.
VIDEO. The specter of a second epidemic wave worries these caregivers
The pilot scheme covers, for the moment, a hotel park of around 400 rooms in Ile-de-France. But it could easily be extended if the Ile-de-France experiment was conclusive. At least that's what the CEO of the Accor group, Sébastien Bazin, suggested last Thursday on France Inter.
The boss of the hotel group had announced that "more than 300" establishments in the chain (out of a total of 1700 in France) were voluntary. "It is about making rooms at cost price (30 to 50 euros) available to asymptomatic but contaminating people," he said. Who will pay the bill? "At this point, I don't know anything about it," concluded Sébastien Bazin.
Paris Newsletter
Every morning, the news of your department seen by Le ParisienI'm registering
Your email address is collected by Le Parisien to allow you to receive our news and commercial offers. Find out more
Our coronavirus topics
- A global crisis: our latest articles published
- In figures: our dashboard to monitor the epidemic
- In questions: the editorial staff's answers to your questions
- The key thing to know: every day at midday, our newsletter to take stock
- Podcast: what are coronaviruses? Diving under the microscope in virus biology
- Call for contributions: tell us about your world from
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/KMEYMJKESBAZBE4MRBAM4TGHIQ.jpg)
